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Summary
Following occupancy of the T cell receptor by antigen, T cell proliferation and lymphokine
production are determined by a second costimulatory signal delivered by a ligand expressed on
antigen presenting cells. The human B cell activation antigen B7, which is expressed on antigen
presenting cells including activatedB cells and 'Y interferon treated monorytes, has been shown
to deliver such a costimulatory signal upon attachment to its ligand onT cells, CD28 . We have
cloned and sequenced the murine homologue ofthehumanB7 gene . The predicted murine protein
has 44% amino acid identity with human B7 . The greatest similarity is in the IgV and Ig-C
like domains . Murine B7 mRNA was detected in murine hematopoietic cells ofB cell but not
T cell origin . Cells transfected with murine B7 provided a costimulatory signal to human
CD28+ T lymphocytes . These results demonstrate the costimulatory activity of murine B7 and
provide evidence that the ligand attachment site is conserved between the two species .
Although occupancy of the TCR complex by antigen in
13, association with theMHC is necessary for the initia-
tion ofT cell activation, several lines of evidence suggest that
a second costimulatory signal is essential for the induction
of proliferation and lymphokine secretion (1-4) . In murine
andhuman systems, this costimulatory signal is delivered by
APC and requires cell to cell contact (2, 4) . Cells which can
deliver this costimulatory signal include activated, but not
resting B lymphocytes (5), INF-y activated monorytes, and
dendritic cells (2, 6) .
Several recent studies inhuman systems have provided com-
pelling evidence that theB cell activation antigen B7 can pro-
vide one such costimulatory signal (7-9) . B7, a member of
the Ig supergene family, has been shown to be a ligand for
another member of this family, the T cell surface protein
CD28, (10-13) . CD28 is constitutively expressed on 95%
of human CD4+ T cells, 50% of CD8+ T cells, and on
thymocytes which coexpress CD4 and CD8 (14-16) . Fol-
lowing suboptimal activation ofT cells with anti-CD3 mAb
(16), anti-CD2 mAb, or phorbol ester (17), crosslinking of
CD28 by anti-CD28 mAb results in enhancedT cell prolifer-
ation and greatly augments synthesis ofmultiple lymphokines
(18) . B7 is likely to be an important regulator ofT cell prolifer-
ation and lymphokine production as evidenced by its pattern
of expression and functional activity . B7 is not expressed on
resting B cells (19) but appears following crosslinking of sur-
face Ig (10, 19) or class II MHC (9) . Moreover, B7 is not
expressed on unstimulated monorytes and is specifically in-
duced by INF-y but not other stimuli which activate mono-
cytes (20) . Human B7 (hB7) 1 transfected cells or recom-
binant B7-Ig fusion protein augment proliferation and induce
IL2, but not IIT4, synthesis inT cells which have been treated
with phorbol ester or anti-CD3 mAb (7-9) .
In murine systems, a homologue for CD28 has recently
been cloned (21) ; however, a conserved functional activity
has not yet been demonstrated . In the present study, we have
cloned, determined the nucleotide sequence, and structur-
ally analyzed the murine homologue ofB7 . We demonstrate
that murine B7 (mB7) is costimulatory for human CD28+
T cells, suggesting the existence of a highly conservedbinding
domain .
Materials and Methods
Isolation ofMurinecDNA Clones.
￿
In preliminary experiments,
low stringency hybridization of the human B7 cDNA insert (10)
to blots of poly(A) + RNA from the murineB cell lines 70Z, A20,
1 Abbreviations used in this paper. CHO, Chinese hamster ovary cells ; hB7,
human 137 ; mB7, murine B7.
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in 70Z and A20 . The 31P-labeled, 1.5-kb human B7 cDNA insert
was used to screen a Xgt11cDNA library generated from the mouse
pre-B cell line, 70Z/3 (22) . Hybridization at reduced stringency
was performed in 5 x SSPE, 5 x Denhardt's solution, 0.2% SDS,
500 Fcg/ml salmon sperm DNA at 50°C . Final washes were in 2x
SSC, 0.1% SDS at 52.5°C for 20 min . A single cDNA clone was
isolated . DNA sequence analysis revealed that it contained a region
homologous to the human B7 Ig-C, transmembrane, cytoplasmic,
and 3' untranslated domains. ThiscDNA insert was used to screen
a cDNA library prepared from the mouse B cell line, A20, in the
pCDM8 vector. Four additional cDNA clones were isolated . One
ofthese was sequenced and found to contain regions homologous
to human B7 5' untranslated, signal peptide, IgV, and Ig-C do-
mains. The Ig-C region was identical between the twocDNA clones
and contained a BamHI restriction enzyme site . A complete mu-
rine B7cDNA clone was constructed by ligation of the 70ZcDNA
clone into the EcoRI site of the eukaryotic expression vector,
pCDNAI (Invitrogen, San Diego, CA), followed by digestion with
BamHI, and ligation of theBamHI fragment from the A20cDNA
clone .
DNA SequenceAnalysis.
￿
B7cDNAinserts were subcloned into
the pKSII - plasmid (Stratagene, La Jolla, CA) . Nested deletions
were constructed using the Erase-A-Base kit according to the
manufacturer's directions (Promega, Madison, WI) . The cDNA
insert was sequenced using dye labeled primers and Taq polymerase
(Applied Biosystems, Foster City, CA) and the sequencing reac-
tions were analyzed on an Applied Biosystems (model 373) auto-
mated fluorescent sequencer. Sequence data obtained from overlap-
ping deletion clones on both strands were assembled to yield the
final murine B7 sequence. These sequence data are available from
EMBL/GenBank/DDBJ under accession number X60958 .
B7 Hybridization Probe.
￿
ADNA fragment corresponding to the
protein coding region of the murine B7cDNA was used as a probe
for RNA and DNA blot hybridizations because of a repetitive
element in the 3' untranslated region of the B7 mRNA . The
complete murine B7cDNA was used as a template for PCR ampli-
fication of the coding region using a sense primer (ATGGCTT
GCAATTGTCAG) and anti-sense primer (CTAAAGGAAGAC-
GGTCT) corresponding to nucleotides 249-266 and 1169-1153 of
thecDNA sequence . The 921 by coding region PCR product was
gel purified and used for all blot hybridizations .
RNA andDNABlot Hybridizations.
￿
RNA was prepared from
various organs isolated from a 4-wk-old Balb/c mouse . RNA was
also prepared from the murine pre-B cell lines 38139 and 300.19,
the B cell lymphomas AJ9, CH1 and A20, the plasmacytoma lines,
Ag8.653 (P3 x 63-Ag8.653) and NS-1 (P3/NSl/1-Ag4-1), the T
cell lymphoma lines, EL4, BW5147, and YAC, and the thymoma
line RADA . RNA preparation, detailed characterizations, and
sources of these cells are as described (23) . 2 Ftg of poly(A)' RNA
were denatured with glyoxyl, electrophoresed on an agarose gel,
and blotted onto nitrocellulose membranes (Schleicher and Schuell,
Keene, NH) . Isolation of genomic DNA and DNA blot hybridi-
zations were performed as described (24) . The 921 by murine B7
coding region PCR product and the actin cDNA insert were la-
beled by random oligonucleotide priming using a-'ZP-labeled
dCTP and the Klenow fragment ofDNA polymerase. Hybridiza-
tion, washing, and autoradiography were performed as previously
described (10, 24) .
Cells .
￿
Human CD28' T cells were isolated from peripheral
blood mononuclear cells as described (7) .
Monoclonal Antibodies.
￿
4B10 (IgG1) is an anti-CD28 mAb (7) .
Optimal stimulation of T cells with anti-CD28mAb was obtained
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at a concentration of 1 jug/ml and this dose was used throughout
the experiments. 41110 was purified using a protein A Sepharose
column (Bio-Rad) as described (7) . The anti-117 mAb, 133, (IgM)
was characterized in our laboratory (10, 19) and was used at a final
concentration of 10 hg/ml .
B7Transfection.
￿
Transient expression of B7cDNA clones inCOS
cells was performed as previously described (11) . COS cells trans-
fected with the pCDNAI vector alone were also prepared . Trans-
fected COS cells were used 72 h after the addition ofDNA . A
stabley transfected Chinese hamster ovary (CHO) cell line expressing
hB7 was constructed as previously described and is referred to as
CHO-hB7 (7) .
Cell Fixation .
￿
COS andCHO cells were detached from tissue
culture plates and fixed with paraformaldehyde as described (7) .
Proliferation Assay .
￿
The capacity ofB7 to costimulate T cell pro-
liferation was measured as described (7) . Briefly, human CD28+
T lymphocytes were stimulated with phorbol myristate 13-acetate
(PMA) (Calbiochem, LaJolla, CA) at 1 ng/ml final concentration
(17) . The fixed CHO-hB7 andCOS cell transfectants were added
at a concentration of 2 x 104 cells/well . The specificity of the
stimulation with COS-hB7 cells was assayed by the addition of anti-
B7mAb to the cultures at a final concentration of 10 pg/ml . The
cells were pulsed with 1 p.Ci of 3H-thymidine (ICN Flow, Costa
Mesa, CA) during the last 8 h of a 72-h culture, harvested onto
filters, and counted .
Results
Isolation ofMurine 117cDNA, Sequencing, and Analysis.
￿
A
murinecDNA clone was isolated by low stringency hybrid-
ization with thehB7cDNA employing acDNA library pre-
pared from the murine pre-B cell line, 70Z. The murinecDNA
isolated from 70Z was composed of 1180 bases of intron fol-
lowed by a splice acceptor and sequences homologous to the
hB7 Ig-C, transmembrane, cytoplasmic, and 3' untranslated
domains . This cDNA was used to isolate additional clones
under stringent conditions from a cDNA library prepared
from the murine B cell line, A20. Comparison of the A20
cDNA clone with hB7 showed that the A20 cDNA con-
tained sequences homologous to thehB7 5' untranslated, signal
peptide, IgV, and Ig-C domains followed by a splice donor
and 1900 bases of intron sequence. This intron DNA con-
tained murine B1 repetitive Alu-like elements . The two mu-
rine cDNA clones share 320 bases of identical sequence cor-
responding to the Ig-C domain . The Ig-C domain contained
a uniqueBamHI site and a complete murine B7 cDNA clone
was constructed by ligating the two cDNA clones at this
BamHI site.
A search of the GenBank and EMBL databases with the
mB7 nucleotide sequence revealed that only the hB7 sequence
exhibited significant homology with the murine sequence
(sigma = 24 SDs above the mean) . Comparison of the mB7
cDNA sequence with that ofhB7 showed that the two were
60% identical. Homologous domains include the 5' (50%)
and 3' (40%) untranslated regions in addition to the protein
coding sequence (63%) . A poly(A) tract following a con-
sensus polyadenylation signal (bases 1678 -1683) was identified.
Analysis of the mB7 cDNA reveals a single, long open
reading frame of 918 bases initiated,by one of three closely
spaced ATG codons beginning at nucleotides 225, 249, and270. We have chosen the second of these ATG codons (nt
249) as the initiating methionine because theDNA sequence
GCTATGG around this ATG is consistent with the consensus
translation initiation sequenceRCCATGG defined by Kozak
(25) . In addition, the region 5' of this ATG is highly similar
(15 of 17 nucleotides identical) to the human start site . Initi-
ation at this methionine predicts an open reading frame of
918 bases encoding a protein of 306 amino acids .
Fig. 1 shows the alignment of the murine and human B7
protein sequences and the structural features associated with
these molecules . The structural domains shown for mB7 are
based on a comparison with hB7 and with other members
of the Ig supergene family. The initiatory methionine codon
is followed by a 37 amino acid signal peptide. The length
of the signal peptide was chosen to correspond to the signal
cleavage site experimentally determined for hB7 expressed in
CHO cells . Amino terminal sequencing of a soluble hB7
purified from the culture media of transfected CHO cells re-
vealed that the mature hB7 began with the amino acid se-
quence valine, isoleucine, histidine, and valine (our unpub-
lished results) . Hydrophobicity analysis reveals that the putative
signal sequence agrees with the profile for a consensus signal
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299 LA9QTVFL*
Figure 1 .
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Comparison ofmurine and human B7 amino acid sequences.
Amino acid identities are indicated with a vertical bar (1). Possible
Winked glycosylation sites are marked with an (*). The signal peptide,
transmembrane, and Cytoplasmic domains are indicated . Ig-like domains
are defined by the cysteines at position 54 and 121 (Ig-V) and 166 and
220 (Ig-C) . ThecDNA sequencedata are available from EMBL/GenBank/
DDBJ under accession number X60958 .
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peptide and that a highly hydrophobic membrane spanning
domain is located at amino acids 248-272. Ig-V (amino acids
38 - 142) and Ig-C (amino acids 143 - 236) domains retain
many of the conserved amino acids important for the struc-
ture of the Ig supergene family (13) . The complete human
and murine B7 protein sequences were 44% identical with
47% identity in the IgV domain and 57% in the Ig-C do-
main . The mB7 transmembrane domain contains two cys-
teine residues, as opposed to three in hB7, and these could
be involved in lipid derivatization or covalent interaction with
other membrane proteins. The mB7 cytoplasmic domain is
not closely related to its human counterpart but retains its
highly charged nature. Both murine and human B7 contain
eight potential Winked glycosylation sites ofwhich four are
conserved between thetwo sequences . Three of thecommon
glycosylation sites were found in the Ig-C domain and one
in the Ig-V domain . The murine and human B7 proteins differ
in that the mB7 exhibits an Ig hinge-like region between
the Ig-C and transmembrane domains . This should confer
greater flexibility to the mB7. The predicted mature mB7
protein would contain 269 amino acids with a mol wt of
30386 kD as opposed to 254 amino acids and 29311 for hB7 .
Glycosylatiorr of the hB7 protein leads to an apparent mol
wt of 44-54 kD and a similar increase would be expected
for mB7 .
A search of the PIR (Protein Identification Resource) and
the Swiss-Prot (Intelligenetics) protein databases with the mB7
protein sequence revealed similarities with several immuno-
globulin variable and constant domains ofhuman and mu-
rine origins. Human B7 was not found in the protein ho-
mology searches because this sequence was not present in
the databases searched . However, searching all three reading
frame translations of theGenbank and EMBL databases with
the mB7 protein sequence showed that homology with hB7
is much greater than all other sequences.
Expression ofB7 mRNA.
￿
ADNA fragment corresponding
to the protein coding region of the mB7 cDNA (basepairs
249-1169) was synthesized using PCR because of the pres-
ence of a repetitive element in the 3' untranslated region of
the B7 mRNA. Using this B7 coding region probe, RNA
blot hybridization analysis ofB7mRNA expression in mu-
rine lymphoid cells revealed thatB7 was expressed in the ma-
ture B cell lines AJ9 and CH1, in the plasmacytoma line
Ag8.653 and at low levels in the matureB cell lineA20 (Fig.
2 A) . Two mRNA transcripts of 2.2 and 3.9 kb were de-
tected in poly(A)+ RNA . This is a more simple transcript
pattern than seen in human B cell lines where transcripts of
1.7, 2.9, 4.2, and 10 kb were detected . A large transcript
(approximately 10 kb) was observed in the pre-B cell line 38139 .
B7 mRNA expression was not detected in the pre-B cell line
300.19, the plasmacytoma line NS-1, or theT cell lines EL4,
BW5147, RADA, and YAC .
RNA blot hybridization analysis of poly(A)+ RNA iso-
lated from murine organs demonstrated that B7 expression
was restricted to murine splenocytes (Fig . 2 B) . No expres-
sion was observed in liver, brain, heart, lung, kidney, muscle,
or thymus. In both murine splenocytes and B cell lines, 2.2
and 3.9 kbmRNA transcripts were identified, with the 2.2Figure 2 .
￿
B7 mRNA expression is B cell restricted . RNA blot analysis of (A) lymphoid cell lines and (B) Balb/c mouse organs. 2 ttg of poly(A)'
RNA were glyoxylated, electrophoresed on agarose gels, and transferred to nitrocellulose. The blot was hybridized with (a) 32P-labeled mB7 coding
region cDNA and reprobed with (b) 32P-labeled rat actin cDNA . The lanes contain RNA from the murine pre-B cell lines, 38B9 and 300.19, the B
cell lines, AJ9, CH1, and A20, the plasmacytoma lines, Ag8.653 and NS-1, and the T cell lines, EIA, BW5147, RADA, and YAC. The mobility
of rRNAs are indicated on the left .
kb transcript predominating . Thus, B7 expression is restricted
in both murine andhuman lymphoid cells to matureB cells,
some pre-B and plasmacytoma cell lines, but is not found
in T cell lines .
DNA Blot Hybridization Analysis ofB7.
￿
DNA blot anal-
ysis to determine the genomic organization ofB7 was per-
formed, using the B7 coding region probe described above
(Fig. 3) . When genomic DNA was digested with eleven
different restriction endonucleases, the B7 coding region probe
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hybridized to between one and five restriction enzyme frag-
ments . Digestion with ApaI or EcoRV produced a single
DNA fragment, consistent with a single copy ofthe B7 gene
per haploid genome . Digestion with Sacl or BcII, which are
not present in the B7 coding region, each produced 5DNA
fragments . These results suggest that the mB7 protein coding
region encompasses approximately 20 kb and is divided into
at least 5 exons . If these correspond to the hB7 genomic or-
ganization, these will encode the signal peptide, IgV, Ig-C,Figure 3 .
￿
GenomicDNA blot analysis ofB7 . 5,ug ofC57BL/6 splenic
DNA were digested with (a) BamH1, (b)Econ (c) Bch, (d) Kpnl, (e) Bglll,
(/} Xbal, (g) EcoRV, (h) Apal, (i) Bgll, U) BstX1, and (k) Sad .DNAs were
electrophoresed in 0.7% agarose, blotted, and hybridized with 32p-labeled
mB7 coding region cDNA. The sizes, in kb, ofmolwt markers are indicated .
transmembrane, and cytoplasmic domains (G. Freeman and
G. Gray, manuscript in preparation) .
MurineandHuman B7 Transfected Cells Stimulate the Prolifer-
ation ofPhorbol Ester Activated Human CD28'" T Cells. We
examined whethermB7 might provide a costimulatory signal
to human CD28+ T cells. Table 1 summarizes one of three
representative experiments. Coincubation of paraformalde-
hyde fixed COS-mB7 or COS-hB7 cells with PMA treated
CD28+ human T cells resulted in 29-fold and 30-fold en-
hancement ofproliferation, respectively, compared to T cells
treated with PMA alone. Addition of anti-hB7 mAb could
completely inhibit the costimulatory activity of COS-hB7
cells but not of COS-mB7 cells . Addition of paraformalde-
hyde fixed CHO-hB7 transfected cells resulted in a 51-fold
increase in proliferation. In contrast, coincubation of PMA
treated T cells with paraformaldehyde fixed COSVector
resulted in no increase in proliferation. Paraformaldehyde fixed
CHO-hB7, COS-hB7, COS-mB7, and COS-Vector trans-
fected cells did not induce untreated human CD28+ cells to
proliferate above media controls .
Discussion
The mB7 homologue was cloned by probing murine B
cell cDNA libraries with the human gene. DNA sequence
analysis of the mB7 cDNA reveals that this gene is closely
related to the hB7 gene and exhibits 63% identity in the pro-
tein coding region. Murine B7 exhibits structural features
similar to the human gene and is composed of a signal pep-
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Table 1 .
￿
Effect of Murine and Human B7 Expressing Cells on
the Proliferation ofPhorbol Ester Treated Human CD28* T Cells
tide, IgV and Ig-C domains, a transmembrane region, and
a cytoplasmic domain. The complete human and murine B7
protein sequences were44% identical overall with 47% iden-
tity in the IgV domain and 57% in the Ig-C domain . Both
murine and human B7 contain four essential cysteine residues
and other conserved amino acids which define the Ig super-
gene family (13) . In the transmembrane domain, mB7 has
two and hB7 has three cysteines that may be involved in lipid
derivatization or crosslinking to other membrane proteins.
Both murine and humanB7 contain eight potential Winked
glycosylation sites ofwhich four are located in conserved po-
sitions in each molecule. These conserved sites are found in
the Ig-V and Ig-C domains and are presumably sites offunc-
tional glycosylation .The signal peptide, transmembrane, and
cytoplasmic domains are less well conserved. An interesting
difference between murine and human B7 is the presence of
an Ig hinge-like sequence (26) adjacent to the transmembrane
domain of the murine protein .
Expression of mB7 mRNA in tissues was restricted to
splenocytes and was not detected in other organs. Transcrip-
tion ofmB7 was detected in mature murine B cell lines (AJ9,
A20, andCHl) and a plasmacytoma line (Ag8.653) and yields
two polyadenylated transcripts of 2.2 and 3.9 kb. A large
10 kb transcript was found in the pre-B cell line 38139 . This
pattern of transcription was reminiscent ofthe largenumber
of hB7 transcripts which included 1.7, 2.9, 4.2, and 10 Kb
mRNAs (10) . The high degree of sequence homology and
pattern ofmRNA expression demonstrate that the hB7 gene
and the murine gene reported here are closely related .
In humans, we and others haveshown that a recombinant
B7-Ig fusion protein or cells expressing B7 can augment
proliferation ofhumanT cells that have been stimulated with
Human CD28* T cells cocultured with :
cpm ± SEM
Media 148 ± 18
PMA 689 ± 48
Anti-CD28 109 ± 17
CHO-hB7 70 ± 2
COS-hB7 47 ± 7
COS-mB7 40 ± 4
COS-Vector 89 ± 28
PMA + anti-CD28 58,646 ± 3,093
PMA + CHO-hB7 34,910 ± 982
PMA + COS-hB7 20,676 ± 897
PMA + COS-mB7 20,081 ± 1,516
PMA + COS-Vector 392 ± 34
PMA + COS-hB7 + anti-hB7 mAb 356 ± 52
PMA + COS-mB7 + anti-hB7 mAb 17,395 ± 1,367phorbol ester or anti-CD3 (7-9) . This stimulation is deliv-
ered via attachment ofB7 to the T cell CD28 glycoprotein
and results in T cell proliferation and secretion of IL2, but
not IL4 . The specificity of this pathway has been demon-
strated by inhibition of proliferation and IL -2 secretion by
mAbs to either B7 or CD28 . MurineT cells express ahomo-
logue of human CD28 which has 68% amino acid identity
to the human gene (21) . The expression of murine CD28
is T cell restricted; however, the existence of a pathway for
T cell activation has not been demonstrated. COS cells trans-
fected with mB7 can act as costimulators ofhuman CD28+
T cells, enhancing proliferation ofCD28+ T cells that have
been treated with phorbol ester. The stimulation of human
T cells by bothmB7 and hB7 shows that the ligand binding
site on B7 is conserved . The interspecies costimulatory ac-
tivity of B7 was somewhat surprising since the protein se-
quence identity was only 44% .
In humans, engagement of theCD28 pathway greatly aug-
ments synthesis of multiple lymphokines including IL-2,
INF-y, tumor necrosis factor a (TNF-a), granulocyte mac-
rophage colony stimulating factor (GM-CSF), but not 1174
(7, 18, 27) . This division oflymphokine synthesis corresponds
to that produced by the Thl subset of T cells in the mouse,
whereas the Th2 subset produces 114 but not IL-2 (28) . In
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